“…To target P. aeruginosa cellular and extracellular carbohydrate interactions, many types of glycomimetics and multivalent glycoconjugates have been suggested as potential anti-infectives and are in various stages of investigation [44,52,54,55,57,59,61,105,106,[108][109][110][111]. Emphasizing the inhibition of the binding of the Pseudomonas lectins, examples include small molecule glycomimetics, glycoclusters, heteroglycoclusters, heteromultivalent gold nanorods, glycodendrimers, glycopolymers, aromatic thioglycosides, glyconanoparticles, and nanotherapeutics with glycomimetic shells [25,52,55,57,61,63,97,[103][104][105][106][107][109][110][111][112][113].…”